2016 International Congress Archives - Page 20 of 207

12:00pm-1:30pm: Epidemiology and economic burden of falls and fractures in patients with Huntington’s disease

D.O. Claassen, P. Donga, S. Rajagopalan, L.M. De Boer, B. Carroll, S. Gandhi (Nashville, TN, USA)

Huntington's disease · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Esophageal involvement in multiple system atrophy

T. Shimohata, H. Taniguchi, H. Nakayama, K. Hori, M. Inoue, M. Nishizawa (Niigata, Japan)

Ataxia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: European pediatric normative values for the scale for assessment and rating of ataxia (SARA)

T.F. Lawerman, R. Brandsma, R.J. Lunsing, J.G.M. Burgerhof, D.A. Sival, On behalf of the Childhood Ataxia and Cerebellar Study Group of the European Pediatric Neurology Society, N. Barisic, P. Baxter, E. Bertini, L. Blumkin, V. Brankovic, G.E. Calabro, C.E. Catsman-Berrevoets, D. Craiu, B. Dan, A. Dica, T. Franciskovic, J. Gburek-Augustat, S. Grunt, H. Hartley, F. Kammoun, C. Kennedy, M.J. Kuiper, I. Lehman, A. Lustenberger, F. Mancini, M. Mirabelli-Badenier, E. Mulder-den Hartog, M. Steinlin, M. Synofzik, C.C. Triki, E.M. Valente, G. Vasco, A. Zekavica (Groningen, Netherlands)

Ataxia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Evaluating bradykinesia: How many finger taps are needed?

E. Ruzicka, R. Krupicka, K. Zarubova, J. Rusz, R. Jech, D. Stanek, Z. Szabo (Praha, Czech Republic)

Phenomenology and clinical assessment of movement disorders · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Evaluating quantitative EEG (QEEG) measures to differentiate between Parkinson’s disease (PD) patients and healthy individuals

M. Chaturvedi, F. Hatz, U. Gschwandtner, V. Roth, P. Fuhr (Basel, Switzerland)

Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Evaluating swallowing function in patients with Huntington disease enrolled in the first-HD study

S.A. Frank, D.O. Claassen, S. Janicki, D. Oakes, D. Stamler, V. Sung, C. Vaughn, C.M. Testa, On behalf of First-HD HSG Investigators (Boston, MA, USA)

Huntington's disease · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Evaluating the effects of deep brain stimulation (DBS) in mice with spinocerebellar ataxia (SCA1)

V. Vedam-Mai, K. McFarland, Q. Zhang, H. Kim, R. Nathu, S. Kurtovic, K. Savery, T. Ashizawa, M.S. Okun (Gainesville, FL, USA)

Ataxia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Evaluating the natural history of prodromal PD in the PARS cohort

D. Jennings, A. Siderowf, M. Stern, K. Marek, PARS Study Investigators (New Haven, CT, USA)

Neuroimaging (non-PD) · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Evaluation of parkinsonism and striatal dopamine transporter loss in patients with spinocerebellar ataxia type 6

T. Xie, D. Appelbaum, J. Bernard, M. Padmanaban, Y. Pu, C. Gomez (Chicago, IL, USA)

Ataxia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Evaluation of quality of life (QOL), patient- and clinician-reported outcomes with deutetrabenazine treatment of chorea in Huntington disease in first-HD

C.M. Testa, D.O. Claassen, D. Oakes, D. Stamler, V. Sung, S. Frank, On behalf of the First-HD HSG Investigators (Richmond, VA, USA)

Huntington's disease · Exhibit Hall located in Hall B, Level 2